1-800-Flowers at 0.13x Sales: The Discount That Isn't a Bargain

1-800-Flowers.com just reported its fiscal fourth quarter and the stock followed, sitting at about $3 — just above its 52-week low of $2.89 and far from the $7.10 it touched about a year ago. The numbers behind the move are a familiar shape: fiscal 2026 revenue fell 10.8% to $1.5 billion, orders were down 17.6% for the year, and the company posted a $134.8 million net loss.

Here is where the casual read goes backwards. A $195 million company selling $1.5 billion a year trades at about 0.13 times revenue. That is not "cheap stock that's been beaten down" — that is a stock the market has already run a liquidation scenario on. The real question this quarter isn't whether FLWS is cheap. It's what the cheap multiple is actually charging you for, and whether the one bright spot in the report can earn back the rest of the business.

The factor stack is degrading, not cheap

Start with growth, because the price is doing its discounting around it. The rate of decline accelerated across the fiscal year, landing at 11.6% in the third quarter and 12.9% in the fourth. Over the full year the company processed 17.6% fewer orders and clawed back only part of it with a 5.5% higher average order value — people are buying a little more per basket, but fewer people are buying at all. The floral-and-gifts segment, which ought to be the identity of the business, fell 17.7% for the year. That is not a cyclical dip. That is a demand line bending downward.

Profitability is the honest part of the story. Management cut costs hard — it hit its original $50 million run-rate savings target ahead of schedule and identified another $15 to $20 million — and that discipline is why full-year adjusted EBITDA landed at a near-breakeven $2.9 million even as the final quarter alone posted a $31 million loss. Guidance for the coming year is a modest profit of $10 to $15 million. On that factor by itself this is not a dying business; it's a breakeven operator with a small positive runway.

But a factor stack is a stack, and the rest is working against it. Growth is degrading. Momentum is poor — the stock is down about 22% year to date and trading at its lows. Revisions are pointing the wrong way, with the fourth quarter missing on both revenue and loss per share after the third quarter did the same. And the safety factor has a catch. This is the profile that produces a low multiple, not a value setup waiting to be exploited.

What 0.13x sales is actually telling you

The market sets that 0.13x multiple against a peer set that has to be a stretch, because there is no clean comparable to a company that ships flowers, gourmet food, and a B2B marketplace for local florists. So I benchmark against broad consumer e-commerce names, with the caveat that the mix is imperfect — and the gap is wide enough that the caveat doesn't rescue "cheap."

Name	Sales multiple (TTM)
1-800-Flowers	~0.13x
Crocs	~1.3x
Gilt	~1.5x
MercadoLibre	~2.7x
eBay	~3.9x

That puts 1-800-Flowers at roughly a tenth of its softest peer's multiple and about a thirtieth of its most expensive. When a multiple is that detached from the band, the usual "it's cheap, buy it" reflex is exactly backwards. A low absolute multiple is not a value signal — it is the market telling you it expects the revenue to keep eroding and/or the shareholders to be diluted.

The dilution part is the live question right now. The company amended its credit agreement to extend covenant relief, and it has retained Guggenheim Securities to evaluate a range of options: public or private debt or equity financing, or divestitures of non-strategic assets. That is the plain-language version of a business that needs more money and is going to ask the market for it. A modest $128 million net-debt position and a $55 million improvement in free cash flow are genuinely good — but they sit under an unresolved raise, and that overhang is a meaningful share of what the $3 price is paying.

The one number that points the other way

There is a single bright line in the report, and it's worth respecting. BloomNet — the side of the business that connects local florists to customers — grew 1.9% in the quarter, the only segment to grow, driven by local marketplace apps like DoorDash and Instacart and improved florist fulfillment. Separately, management reports that selling its own goods through third-party marketplaces like Amazon and Instacart is showing positive contribution margins with minimal cannibalization of the core site. That channel is the credible path to a revenue inflection: it meets customers where the search-engine traffic already is, without burning the old marketing budget that was cut back.

So the investment case reduces to one thing: can marketplace and customer-lifetime-value strategies turn the order line back up? Seven and a half million customers, 77% of revenue from existing accounts, and a loyalty program covering 800,000 members are the raw material. If orders stop falling and the $10 to $15 million EBITDA guide is met, the multiple has room to re-rate toward the peer band, even at a discount. If orders keep falling, the "cheap" multiple is the destination, not the starting point — and the dilutive raise pushes the price lower in dollars even as it holds in multiples.

For a portfolio, I'd treat FLWS as a name to watch, not a buy. It is not a barbell-quality leg and not a value setup on the factor stack — it's a shrinking-revenue, near-breakeven business with a capital raise pending, which is a speculative risk/reward, not a GARP hold. The trigger that changes it is concrete: a quarter where order volume turns positive off the marketplace channels, plus a raise that doesn't badly dilute existing holders. Until both show up, the honest read of a $3, 0.13x-sales flower stock is not "bargain." It's "the market has done its pricing, and the evidence so far mostly confirms it."